Keyur Patel Selected Research

Keyur Patel Research Topics

Disease

41	Chronic Hepatitis C 10/2016 - 03/2002
40	Fibrosis (Cirrhosis) 01/2022 - 03/2002
33	Infections 01/2022 - 03/2002
22	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2013
21	Neoplasms (Cancer) 05/2022 - 05/2013
17	Hepatitis C 01/2019 - 11/2002
15	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 03/2003
13	Non-alcoholic Fatty Liver Disease 04/2022 - 05/2010
9	Inflammation (Inflammations) 01/2022 - 03/2002
8	Disease Progression 12/2016 - 11/2002
7	Wounds and Injuries (Trauma) 02/2022 - 10/2016
7	Liver Diseases (Liver Disease) 12/2021 - 01/2006
6	Anemia 01/2022 - 11/2003
6	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2021 - 11/2015
6	Insulin Resistance 01/2019 - 10/2009
5	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 05/2006
5	Virus Diseases (Viral Diseases) 08/2012 - 02/2004
4	Philadelphia Chromosome 10/2021 - 03/2017
4	Hemolytic Anemia 02/2014 - 10/2010
3	Pruritus (Itching) 06/2022 - 01/2020
3	Chromosome Aberrations (Chromosome Abnormalities) 01/2022 - 03/2017
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2021 - 01/2019
3	Autoimmune Diseases (Autoimmune Disease) 09/2021 - 01/2006
3	Ulcer 05/2021 - 02/2021
3	Tuberous Sclerosis (Bourneville's Disease) 10/2017 - 11/2016
3	Inborn Genetic Diseases (Disease, Hereditary) 10/2017 - 11/2016
3	Residual Neoplasm 04/2017 - 01/2016
3	Body Weight (Weight, Body) 05/2013 - 03/2002
2	Isochromosomes 05/2022 - 01/2022
2	Cataract (Cataracts) 01/2022 - 01/2021
2	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2018
2	Leukocytosis (Pleocytosis) 01/2022 - 01/2017
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2021 - 03/2017
2	Diabetic Foot 05/2021 - 02/2021
2	Renal Insufficiency (Renal Failure) 01/2021 - 07/2005
2	B-Cell Lymphoma (Lymphoma, B Cell) 09/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

23	Biomarkers (Surrogate Marker)IBA 06/2022 - 12/2004
21	Ribavirin (Virazole)FDA LinkGeneric 10/2016 - 03/2002
17	InterferonsIBA 01/2019 - 03/2002
17	Antiviral Agents (Antivirals)IBA 01/2018 - 10/2002
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2004
9	Alanine Transaminase (SGPT)IBA 01/2021 - 03/2002
8	RNA (Ribonucleic Acid)IBA 05/2013 - 03/2002
6	Biological ProductsIBA 05/2022 - 07/2002
6	Interferon-alpha (Interferon Alfa)IBA 02/2012 - 05/2004
4	venetoclaxIBA 01/2022 - 01/2019
4	farglitazarIBA 01/2022 - 04/2010
4	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2016
4	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 01/2018
4	CytokinesIBA 11/2018 - 06/2006
4	LipidsIBA 12/2016 - 06/2010
4	SofosbuvirIBA 10/2016 - 05/2013
4	Inosine TriphosphataseIBA 02/2014 - 10/2010
3	cilofexorIBA 06/2022 - 01/2020
3	ImmunosorbentsIBA 01/2022 - 10/2009
3	Collagen Type III (Type III Collagen)IBA 01/2022 - 02/2015
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 01/2016
3	Core Binding Factors (Core-Binding Factor)IBA 01/2022 - 10/2014
3	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 01/2021
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2018
3	ibrutinibIBA 12/2021 - 01/2019
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021 - 01/2016
3	Pharmaceutical PreparationsIBA 09/2021 - 02/2006
3	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2020 - 10/2010
3	Complement C3 (C3 Complement)IBA 01/2019 - 02/2015
3	Janus Kinase 2IBA 01/2019 - 05/2013
3	ruxolitinibIBA 01/2018 - 05/2013
3	trans-sodium crocetinate (crocetin)IBA 10/2017 - 11/2016
3	fms-Like Tyrosine Kinase 3IBA 04/2017 - 01/2016
3	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2017 - 10/2014
3	Peptides (Polypeptides)IBA 02/2015 - 02/2006
3	Hyaluronic Acid (Hyaluronan)IBA 12/2014 - 03/2003
3	Pregnancy-Associated alpha 2-Macroglobulins (alpha 2 Macroglobulin)IBA 12/2014 - 12/2004
3	CholesterolIBA 07/2012 - 06/2010
3	Interferon LambdaIBA 12/2010 - 06/2010
2	CreatinineIBA 04/2022 - 01/2022
2	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 09/2017
2	Decitabine FDA Link 01/2022 - 10/2017
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 01/2021
2	Monoclonal AntibodiesIBA 01/2022 - 02/2009
2	EnzymesIBA 01/2022 - 12/2014
2	Interleukin-2 (IL2)IBA 01/2022 - 12/2014
2	SuspensionsIBA 01/2022 - 01/2021
2	Adenosine Triphosphate (ATP)IBA 12/2021 - 01/2019
2	fludarabineIBA 12/2021 - 10/2014
2	Drug CombinationsIBA 01/2021 - 01/2011
2	CollagenIBA 01/2021 - 01/2019
2	BilirubinIBA 01/2021 - 09/2018
2	Bile Acids and Salts (Bile Acids)IBA 01/2021 - 01/2020
2	Keratin-18 (Keratin 18)IBA 01/2021 - 05/2014
2	NucleophosminIBA 01/2019 - 11/2016

Therapy/Procedure

64	Therapeutics 06/2022 - 03/2002
14	Drug Therapy (Chemotherapy) 01/2022 - 08/2013
10	Liver Transplantation 08/2022 - 07/2005
3	Transplantation 12/2021 - 01/2017
3	Precision Medicine 12/2021 - 04/2014
3	Aftercare (After-Treatment) 01/2021 - 03/2003
3	Stem Cell Transplantation 07/2020 - 01/2016
2	Surgical Amputation (Amputations) 05/2021 - 02/2021
2	Immunotherapy 09/2020 - 01/2017